Long-Term Monitoring of Everolimus Concentrations in Routine Clinical Practice: Evaluation of Patient Percentiles as Quality Indicator and Impact of Analytical Method Change
Background: Everolimus, an mTOR inhibitor used in oncology and organ transplantation, requires therapeutic drug monitoring due to the narrow therapeutic range of everolimus and substantial pharmacokinetic variation. Patient-derived data can function as a supplementary quality indicator for laboratory methods by providi...